Literature DB >> 11588047

Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.

M B Faries1, I Bedrosian, S Xu, G Koski, J G Roros, M A Moise, H Q Nguyen, F H Engels, P A Cohen, B J Czerniecki.   

Abstract

Mature dendritic cells (DCs), in addition to providing costimulation, can define the Th1, in contrast to the Th2, nature of a T-cell response through the production of cytokines and chemokines. Because calcium signaling alone causes rapid DC maturation of both normal and transformed myeloid cells, it was evaluated whether calcium-mobilized DCs polarize T cells toward a Th1 or a Th2 phenotype. After human monocytes were cultured for 24 hours in serum-free medium and granulocyte-macrophage colony-stimulating factor to produce immature DCs, additional overnight culture with either calcium ionophore (CI) or interferon gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and soluble CD40L resulted in phenotypically mature DCs that produced interleukin-8 (IL-8) and displayed marked expression of CD80, CD86, CD40, CD54, CD83, DC-LAMP, and RelB. DCs matured by IFN-gamma, TNF-alpha, and soluble CD40L were additionally distinguished by undetectable CD4 expression, marked secretion of IL-12, IL-6, and MIP-1beta, and preferential ability to promote Th1/Tc1 characteristics during T-cell sensitization. In contrast, DCs matured by CI treatment were distinguished by CD4 expression, modest or absent levels of IL-12, IL-6, and MIP-1beta, and preferential ability to promote Th2/Tc2 characteristics. Calcium signaling selectively antagonized IL-12 production by mature DCs activated with IFN-gamma, TNF-alpha, and soluble CD40L. Although the activation of DCs by calcium signals is largely mediated through calcineurin phosphatase, the inhibition of IL-12 production by calcium signaling was independent of this enzyme. Naturally occurring calcium fluxes in immature DCs, therefore, negatively regulate Dc1 differentiation while promoting Dc2 characteristics and Th2/Tc2 polarization. Calcium-mobilized DCs may have clinical usefulness in treating disease states with excessive Th1/Tc1 activity, such as graft-versus-host disease or autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588047     DOI: 10.1182/blood.v98.8.2489

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Dendritic cells in melanoma immunotherapy.

Authors:  Mark B Faries; Brian J Czerniecki
Journal:  Curr Treat Options Oncol       Date:  2005-05

2.  Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.

Authors:  Cord Naujokat; Carsten Berges; Alexandra Höh; Hubert Wieczorek; Dominik Fuchs; Jörg Ovens; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel
Journal:  Immunology       Date:  2006-11-03       Impact factor: 7.397

3.  Pasteurella multocida toxin activates human monocyte-derived and murine bone marrow-derived dendritic cells in vitro but suppresses antibody production in vivo.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; George K Lewis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  The plasticity and potential of leukemia cell lines to differentiate into dendritic cells.

Authors:  Qingwei Guo; Leling Zhang; Fu Li; Guosheng Jiang
Journal:  Oncol Lett       Date:  2012-07-25       Impact factor: 2.967

5.  Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer.

Authors:  Lea Lowenfeld; Salman Zaheer; Crystal Oechsle; Megan Fracol; Jashodeep Datta; Shuwen Xu; Elizabeth Fitzpatrick; Robert E Roses; Carla S Fisher; Elizabeth S McDonald; Paul J Zhang; Angela DeMichele; Rosemarie Mick; Gary K Koski; Brian J Czerniecki
Journal:  Oncoimmunology       Date:  2016-07-01       Impact factor: 8.110

6.  Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.

Authors:  Dipyaman Ganguly; Kausik Paul; Jayashree Bagchi; Srabanti Rakshit; Labanya Mandal; Gautam Bandyopadhyay; Santu Bandyopadhyay
Journal:  Immunology       Date:  2007-04-13       Impact factor: 7.397

7.  Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis.

Authors:  N Kumar Tripathy; S Kumar Chauhan; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

8.  Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathway.

Authors:  Danish Umar; Arundhoti Das; Suman Gupta; Somdeb Chattopadhyay; Debayan Sarkar; Gauri Mirji; Jeet Kalia; Gopalakrishnan Aneeshkumar Arimbasseri; Jeannine Marie Durdik; Satyajit Rath; Anna George; Vineeta Bal
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

9.  Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; George K Lewis
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.

Authors:  T Abe; I Fuse; M Narita; M Takahashi; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.